PARK2 polymorphisms predict disease progression in patients infected with hepatitis C virus

Journal Title: Annals of Hepatology - Year 2016, Vol 15, Issue 6

Abstract

Background. The protein encoded by PARK2 gene is a component of the ubiquitin-proteasome system that mediates targeting of proteins for the degradation pathway. Genetic variations at PARK2 gene were linked to various diseases including leprosy, typhoid and cancer. The present study investigated the association of single nucleotide polymorphisms (SNPs) in the PARK2 gene with the development of hepatitis C virus (HCV) infection and its progression to severe liver diseases. Material and methods. A total of 800 subjects, including 400 normal healthy subjects and 400 HCV-infected patients, were analyzed in this study. The patients were classified as chronic HCV patients (group I), patients with cirrhosis (group II) and patients with hepatocellular carcinoma (HCC) in the context of cirrhosis (group III). DNA was extracted and was genotyped for the SNPs rs10945859, rs2803085, rs2276201 and rs1931223. Results. Among these SNPs, CT genotype of rs10945859 was found to have a significant association towards the clinical progression of chronic HCV infection to cirrhosis alone (OR = 1.850; 95% C. I. 1.115-3.069; p = 0.016) or cirrhosis and HCC (OR = 1.768; 95% C. I. 1.090-2.867; p value = 0.020). Conclusion. SNP rs10945859 in the PARK2 gene could prove useful in predicting the clinical outcome in HCV-infected patients.

Authors and Affiliations

Mashael Al-Anazi, Ahmed Al-Qahtani, Fahad Al-Zoghaibi, Ayman Abdo, Faisal Sanai, Waleed Al-Hamoudi, Khalid Alswat, Hamad Al-Ashgar, Mohammed Khan, Ali Albenmousa, Hanif Khalak, Mohammed Al-Ahdal

Keywords

Related Articles

Variability of apparent diffusion coefficients in metastatic small cell lung carcinoma: comparisons between-within normal tissue and liver metastases

In recent years, the use of diffusion weighted MRI (DW-MRI) has increased for the diagnosis of focal liver lesions (FLLs). DW-MRI may help in the differentiation of benign and malignant FLLs by measuring the apparent dif...

Surgical morbidity in severely obese liver transplant recipients - A single Canadian Centre Experience

The prevalence of obesity is increasing globally, with nearly half of a billion of the world’s population now considered to be overweight or obese. Obesity and overweight patients are one of the major health issues in Ca...

Pegylated interferon-alpha2b plus ribavirin for the treatment of chronic hepatitis C virus genotype 4 infection in patients with normal serum ALT

Background. Approximately one-third of patients with chronic hepatitis C virus infection have persistently normal liver enzymes reflected by a normal serum alanine transaminase (ALT). Data with regards the efficacy and s...

Treatment of HCV infected patients and renal disease

Hepatitis C signifies a highly prevalent infection in patients with end stage renal disease. Most frequently it is associated to glomerulonephritis, patients on hemodyalisis and renal transplants. The prevalence of HCV a...

Download PDF file
  • EP ID EP207220
  • DOI -
  • Views 81
  • Downloads 0

How To Cite

Mashael Al-Anazi, Ahmed Al-Qahtani, Fahad Al-Zoghaibi, Ayman Abdo, Faisal Sanai, Waleed Al-Hamoudi, Khalid Alswat, Hamad Al-Ashgar, Mohammed Khan, Ali Albenmousa, Hanif Khalak, Mohammed Al-Ahdal (2016). PARK2 polymorphisms predict disease progression in patients infected with hepatitis C virus. Annals of Hepatology, 15(6), 824-833. https://europub.co.uk/articles/-A-207220